var data={"name":"Oncology","type":"SPECIALTY","numTopics":"11,000","numSpecialties":"over 22","items":[{"name":"Breast cancer","type":"SECTION","url":"toc.htm?path=oncology/breast-cancer"},{"name":"Cancer survivorship","type":"SECTION","url":"toc.htm?path=oncology/cancer-survivorship"},{"name":"Chemotherapeutic agents","type":"SECTION","url":"toc.htm?path=oncology/chemotherapeutic-agents"},{"name":"End of life care","type":"SECTION","url":"toc.htm?path=oncology/end-of-life-care"},{"name":"Endocrine tumors","type":"SECTION","url":"toc.htm?path=oncology/endocrine-tumors"},{"name":"Gastrointestinal cancer","type":"SECTION","url":"toc.htm?path=oncology/gastrointestinal-cancer"},{"name":"General oncologic issues","type":"SECTION","url":"toc.htm?path=oncology/general-oncologic-issues"},{"name":"Genitourinary cancer","type":"SECTION","url":"toc.htm?path=oncology/genitourinary-cancer"},{"name":"Gynecologic oncology","type":"SECTION","url":"toc.htm?path=oncology/gynecologic-oncology"},{"name":"Head and neck cancer","type":"SECTION","url":"toc.htm?path=oncology/head-and-neck-cancer"},{"name":"Leukemia myeloproliferative disorders","type":"SECTION","url":"toc.htm?path=oncology/leukemia-myeloproliferative-disorders"},{"name":"Lung cancer","type":"SECTION","url":"toc.htm?path=oncology/lung-cancer"},{"name":"Lymphoma","type":"SECTION","url":"toc.htm?path=oncology/lymphoma"},{"name":"Miscellaneous tumors","type":"SECTION","url":"toc.htm?path=oncology/miscellaneous-tumors"},{"name":"Neurooncology","type":"SECTION","url":"toc.htm?path=oncology/neurooncology"},{"name":"Plasma cell disorders","type":"SECTION","url":"toc.htm?path=oncology/plasma-cell-disorders"},{"name":"Prostate cancer","type":"SECTION","url":"toc.htm?path=oncology/prostate-cancer"},{"name":"Radiation therapy","type":"SECTION","url":"toc.htm?path=oncology/radiation-therapy"},{"name":"Skin cancer","type":"SECTION","url":"toc.htm?path=oncology/skin-cancer"},{"name":"Society guidelines in Oncology","type":"SECTION","url":"toc.htm?path=oncology/society-guidelines-in-oncology"},{"name":"Soft tissue and bone tumors","type":"SECTION","url":"toc.htm?path=oncology/soft-tissue-and-bone-tumors"},{"name":"Tumors immunocompromised host","type":"SECTION","url":"toc.htm?path=oncology/tumors-immunocompromised-host"},{"name":"What's new in oncology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=whats-new-in-oncology"},{"name":"Patient Education","type":"SPECIALTY","url":"toc.htm?path=patient-education"}]}